Contract Manufacturing
First announced in June 2021, this site will be WuXi STA's second facility in the United States, offering expanded capacity and greater flexibili...
August 17, 2022 | News
WuXi ATU will license to Janssen its TESSA™ technology, a high-performance system that can produce 10 times more adeno-associated viral (AAV) vectors...
August 12, 2022 | News
Reduces process development time by an estimated 40 percent Enables biopharmaceutical companies to increase the speed to clinical manufacturing ...
August 10, 2022 | News
GreenLight's messenger RNA production process is transferable to large-scale equipment and CMO facilities Technology transfer and scale-up from lab benc...
August 02, 2022 | News
Released consolidated financial position of the company based on its full acquisition of Samsung Bioepis completed on April 20, 2022 Achieved recor...
July 28, 2022 | News
This investment will establish a cutting-edge, fully integrated CRDMO center in Singapore, including a research and development service center and large-...
July 20, 2022 | News
Acquires additional land, sized 357,366㎡ valued at KRW 426 billion, for Bio Campus 2 Plans to build Multi-Modal Plant, Open Innovation,...
July 19, 2022 | News
Through this agreement, both companies will strategically cooperate in the overall development process, such as discovery, manufacturing, and clinical tria...
July 15, 2022 | News
GenScript ProBio and ACT Therapeutics are in the process of signing a contract for plasmid and virus vector development and production for the first pipe...
July 13, 2022 | News
Aims to build an eco-friendly business environment and achieve net zero GHG emissions in its operations, moving towards 100% renewable energy. Details n...
July 12, 2022 | News
Under the partnership, AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing, ADC conjugation process developm...
July 08, 2022 | News
WuXi STA, a subsidiary of WuXi AppTec, today announced the opening of a new large-scale oligonucleotide and peptide manufacturing facility at its Chan...
July 07, 2022 | News
WuXi Biologics ("WuXi Bio") (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG14 fac...
July 05, 2022 | News
The new blister packaging equipment is identical to that available across Catalent's clinical supply services network, offering maximum access and flexibil...
June 30, 2022 | News
Most Read
Bio Jobs
News
Editor Picks